Internal Medicine, Hematology & Oncology · Jersey City, NJ
NPI
1306098827
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1 Exchange Pl Fl 1
Jersey City, NJ, 07302
Phone (201) 333-8248
Groups this clinician bills Medicare through
Medicare paid, 2024
$997K
68,982 services
Medicare patients, 2024
162
Average age 73
Drug cost, 2024
$2.0M
765 prescriptions
Company payments, 2025
$166K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amit A Patel was code 36415 (venipuncture blood collection), 598 times for 112 patients. In total Amit A Patel billed 68,982 services in 83 codes, and Medicare paid $997K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 598 | 112 | $8.65 | $5,173 |
| 99214 Office E&M - Established | Office | 448 | 124 | $116.97 | $52K |
| 85025 Blood Count | Office | 427 | 91 | $7.52 | $3,213 |
| 96367 Intravenous Infusion, Hydration | Office | 219 | 17 | $26.88 | $5,887 |
| 96372 Injection Administration | Office | 172 | 30 | $13.25 | $2,279 |
| 96365 Intravenous Infusion, Hydration | Office | 136 | 25 | $57.89 | $7,873 |
| 99215 Office E&M - Established | Office | 120 | 58 | $156.10 | $19K |
| 96413 Chemotherapy Administration | Office | 102 | 15 | $125.87 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 81 | 44 | $15.10 | $1,223 |
| 85027 Blood Count | Office | 24 | 13 | $6.34 | $152 |
| 99204 Office E&M - New | Office | 14 | 14 | $157.16 | $2,200 |
| 99205 Office E&M - New | Office | 11 | 11 | $205.99 | $2,266 |
By year: 2022 $746K for 85,282 services; 2023 $722K for 79,490 services; 2024 $997K for 68,982 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 598 | 112 | $8.65 | $5,173 |
| 85025 Blood Count | 427 | 91 | $7.52 | $3,213 |
| 85027 Blood Count | 24 | 13 | $6.34 | $152 |
Medicare prescription drug claims, 2024
In 2024, the drug Amit A Patel prescribed most often to Medicare patients was Anastrozole, with 105 prescriptions and refills. In total Amit A Patel wrote 765 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 105 | 195 | 24 | $1,510 |
| Procrit Epoetin Alfa | 40 | 42 | Under 11 | $124K |
| Eliquis Apixaban | 35 | 41 | Under 11 | $24K |
| Aranesp Darbepoetin Alfa In Polysorbat | 30 | 30 | Under 11 | $83K |
| Prednisone Generic | 24 | 24 | Under 11 | $54.18 |
| Letrozole Generic | 21 | 45 | Under 11 | $308 |
| Hydroxyurea Generic | 17 | 17 | Under 11 | $209 |
| Exemestane Generic | 17 | 17 | Under 11 | $1,007 |
| Imatinib Mesylate Generic | 15 | 15 | Under 11 | $1,087 |
| Neulasta Pegfilgrastim | 15 | 15 | Under 11 | $90K |
| Zirabev Bevacizumab-Bvzr | 15 | 15 | Under 11 | $104K |
| Bicalutamide Generic | 15 | 15 | Under 11 | $156 |
| Acyclovir Generic | 13 | 17 | Under 11 | $161 |
| Prolia Denosumab | 13 | 78 | Under 11 | $22K |
| Tecentriq Atezolizumab | 13 | 13 | Under 11 | $140K |
Brand drugs: 272 claims; generic drugs: 493 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amit A Patel $166K ($166K in general payments such as food, travel and fees) from 27 companies. The largest payer was Daiichi Sankyo Inc. with $84K.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 66 | $84K |
| AstraZeneca Pharmaceuticals LP AZN | 36 | $50K |
| Incyte Corporation INCY | 21 | $19K |
| Jazz Pharmaceuticals Inc. JAZZ | 11 | $13K |
| Adaptive Biotechnologies Corporation ADPT | 3 | $292 |
| Caris MPI, Inc. | 4 | $153 |
| Abbvie Inc. ABBV | 2 | $37.68 |
| Pfizer Inc. PFE | 2 | $37.36 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $35.39 |
| Geron Corporation GERN | 2 | $33.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.